DrSeq Precision Medicine and Pharmacogenomics testing

Precision medicine is reshaping modern healthcare by moving away from a one-size-fits-all approach and advancing care that’s tailored to genetic profiles, lifestyle, and environment. With breakthrough technologies, it’s possible to identify which treatments work best for each patient while reducing unwanted side effects. At the heart of this transformation is comprehensive genomic testing. Solutions such as advanced long-read sequencing, specialized biomarker analysis, and pharmacogenomics are now making it possible to deliver actionable insights for oncology, chronic diseases, and personalized drug response. Nucleome Informatics, through its trusted DrSeq platform, offers industry-leading solutions in this space: 4 Biomarker WGS HiFi: A highly accurate, long-read whole genome sequencing test for cancer that enables the detection of critical variants and structural changes, improving diagnostic accuracy and patient stratification. Axiom Asia Precision Medicine Research Array: A research-oriented genotyping platform tailored for Asian populations, enabling large-scale screening, risk profiling, and pharmacogenomics research with over 750,000 carefully curated genetic markers. Pharmacofocus: An advanced pharmacogenomics panel delivering clinically relevant analysis of drug metabolism and response genes to support drug development and truly personalized treatment choices. Nucleome’s commitment is to empower clinicians and researchers with the most sophisticated genomics and bioinformatics platforms—driving a future where every therapy is informed by individual genomics. #PrecisionMedicine #Genomics #Biomarkers #Pharmacogenomics #PersonalizedHealthcare #Nucleome #DrSeq